Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Obama Budget Counts On FOB Savings For Health Reform – But How, And How Much, Are Open Questions

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA would receive funds to create infrastructure for allowing drug reimportation, under sketch of 2010 budget.

You may also be interested in...



Follow The Follow-On Money: Obama’s Budget Has Modest Biogeneric Savings

The fiscal 2010 federal budget outlined by the Obama administration Feb. 25 takes a conservative view of the fiscal benefit of generic biologics - estimating they will contribute $9.2 billion over 10 years to help pay for health care reform

More Coverage, More Rebates: Increased Medicaid Rx Rebate Would Help Support Proposed Health Reform Fund

The administration’s budget for 2010 includes raising the minimum rebate for Medicaid drugs to 22.1 percent.

More Coverage, More Rebates: Increased Medicaid Rx Rebate Would Help Support Proposed Health Reform Fund

The administration’s budget for 2010 includes raising the minimum rebate for Medicaid drugs to 22.1 percent.

Related Content

Topics

UsernamePublicRestriction

Register

PS069055

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel